The goal of this clinical trial is to learn if/how an AI chatbot can support patients who in recovery for substance use, specifically those who are receiving medication for opioid use disorder. Can the chatbot help lower drug use? Can the chatbot help improve clinical appointment adherence? Can the chatbot help patients build self-efficacy in leading their own recovery journey? Will the chatbot help reduce workload burden for primary care teams? Can the chatbot serve as a safe, useful and engaging tool to support patients? Researchers will investigate the effects of using a chatbot to support follow-up care for patients in opioid use recovery. Participants will: * Receive access to a chatbot for 12 weeks that they can use to prepare for upcoming clinical appointments, find community resources, learn about urge-surfing and wellness techniques, and query for assistance with other recovery-related information and tasks * Complete surveys and provide user feedback
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Enrollment
55
Participants will: * Participate in a baseline session to complete an initial survey and get trained on using the chatbot * Use the chatbot for 12 weeks and submit a brief weekly survey to provide feedback * Complete a final survey to provide substance use and health information as well as give feedback on the experience using the chatbot * Allow access to a limited set of demographic, substance use and health information in electronic health record for study analyses and context.
Massachusetts General Hospital
Boston, Massachusetts, United States
Change in SUD severity
Addiction Severity Index (ASI) Drugs composite score; Scored 0-7 with higher scores indicating increasing severity
Time frame: 12 weeks
Change in psychological health (Anxiety)
General Anxiety Disorder-7 (GAD-7); scored 0-21 with higher scores indicating increasing anxiety
Time frame: 12 weeks
Change in psychological health (Depression)
Patient Health Questionnaire-8 (PHQ-8); scored 0-24 with higher scores indicating more severe depression
Time frame: 12 weeks
Change in self-efficacy for managing chronic conditions (Emotions)
PROMIS Short Form 8a (Managing Emotions); scored from 8-40 with higher scores indicating higher confidence managing emotions
Time frame: 12 weeks
Change in self-efficacy for managing chronic conditions (Social Interactions)
PROMIS Short Form 8a (Social Interactions); scored from 8-40 with higher scores indicating higher confidence with managing social interactions
Time frame: 12 weeks
Change in quality of life
World Health Organization Quality of Life (WHOQoL-BREF) Assessment; higher scores indicate higher quality of life
Time frame: 12 weeks
Change in social needs
Accountable Health Communities Health-Related Social Needs (AHC HRSN) screening; higher scores indicate higher unmet social needs
Time frame: 12 weeks
Chatbot usability
Chatbot Usability Questionnaire (CUQ); scored 0-100 with higher scores indicating higher usability
Time frame: End of 12 week intervention
User Satisfaction
Net Promoter Score (NPS); scored -100 to 100 with higher scores indicating higher user satisfaction
Time frame: End of 12 week intervention
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.